PATHWAY HEALTH CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.006 EUR | -40.00% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 15.84 | 3.873 |
| Enterprise Value (EV) 1 | 16.14 | 9.747 |
| P/E ratio | -1.05 x | -0.46 x |
| Yield | - | - |
| Capitalization / Revenue | 1,453,459 x | 382,516 x |
| EV / Revenue | 1,481,237 x | 962,806 x |
| EV / EBITDA | -2,604,140 x | -1,457,350 x |
| EV / FCF | -4,782,754 x | -3,927,447 x |
| FCF Yield | -0% | -0% |
| Price to Book | 3.67 x | -1.1 x |
| Nbr of stocks (in thousands) | 93,409 | 93,722 |
| Reference price 2 | 0.1695 | 0.0413 |
| Announcement Date | 4/26/22 | 4/25/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net sales | - | 10.9 | 10.12 |
| EBITDA | - | -6.197 | -6.688 |
| EBIT 1 | -1.498 | -6.453 | -6.976 |
| Operating Margin | - | -59.23% | -68.91% |
| Earnings before Tax (EBT) 1 | -1.498 | -8.892 | -8.351 |
| Net income 1 | -1.498 | -8.866 | -8.351 |
| Net margin | - | -81.38% | -82.49% |
| EPS | - | -0.1612 | -0.0891 |
| Free Cash Flow | - | -3.374 | -2.482 |
| FCF margin | - | -30.97% | -24.51% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 5/31/21 | 4/26/22 | 4/25/23 |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net Debt 1 | - | 0.3 | 5.87 |
| Net Cash position 1 | 0 | - | - |
| Leverage (Debt/EBITDA) | - | -0.0488 x | -0.8784 x |
| Free Cash Flow | - | -3.37 | -2.48 |
| ROE (net income / shareholders' equity) | - | -450% | -2,076% |
| ROA (Net income/ Total Assets) | - | -90.9% | -62.9% |
| Assets 1 | - | 9.753 | 13.29 |
| Book Value Per Share | - | 0.0500 | -0.0400 |
| Cash Flow per Share | - | 0.0300 | 0 |
| Capex | - | 0.1 | 0 |
| Capex / Sales | - | 0.91% | 0.04% |
| Announcement Date | 5/31/21 | 4/26/22 | 4/25/23 |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 605K | |
| +22.03% | 88.99B | |
| -24.23% | 74.82B | |
| +1.06% | 26.63B | |
| +3.92% | 17.88B | |
| -14.02% | 16.43B | |
| +1.91% | 15.77B | |
| +75.89% | 13.21B | |
| +69.64% | 13.08B | |
| +39.40% | 12.9B |
- Stock Market
- Equities
- KL1 Stock
- Financials Pathway Health Corp.
